Primary anetoderma and antiphospholipid antibodies - Review of the literature

Clinical Reviews in Allergy and Immunology

Volumn 32, Issue 2, 2007, Pages 162-166

  Hodak, Emmilia ^a,b   David, Michael ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibodies; Antiphospholipid; Primary anetoderma

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ANETODERMA; ANTIBODY PRODUCING CELL; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOLOGY; LUPUS ERYTHEMATOSUS; PATHOPHYSIOLOGY; REVIEW; SKIN DEFECT; SKIN DISEASE;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASES; DERMIS; ELASTIC TISSUE; HUMANS; SKIN DISEASES;

EID: 35348925376     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-0011-1     Document Type: Review

References (49)

1. Thibierge MG (1891) Atrophodermie erythemateux en plaques, a progression exentrique. Ann Dermatol Syphil 2:1004-1005
2. Thibierge MG (1905) Le lupus erythemateux a forme d'atrophodermie en plaques. Ann Dermatol Syphil 6:913-926
3. Heuss-Zurich E (1901) Beitrag zur Kenntnis der atrophia maculosa cutis. (Anetodermai erythematodes Jadassohn) Monatsschr Prakt Dermatol 32:1-20
4. Nomland R (1932) Macular atrophy: lupus erythematosus. Arch Dermatol. 26:1118-1119. Abstract
5. Rosen I (1936) Primary macular atrophy: lupus erythematosus. (Schweminger and Buzzi). Arch Dermatol 33:580. Abstract
6. Scull RH, Nomland R (1937) Secondary macular atrophy: a study of 12 cases occurring in connection with various disorders, with consideration of pathologic relationships. Arch Dermatol 36:809-820
7. Margarot J, Rimbaud P, Raviore J (1939) Lupus erythemateux fixe et anetodermie de Jadassohn. Bull Soc Dermatol Syphil 46:1003-1008
8. Milian G, De Douhet J (1937) Anetodermie en taches et lupus erythemateux. Bull Soc Fr Dermatol Syphil 44:1830-1831
9. Lewis GM (1943) Lupus erythematosus (discoid type): macular atrophy (primary). Arch Dermatol 47:759-760. Abstract
10. Cipollaro AC (1952) Macular atrophy (Schweninger-Buzzi type): chronic discoid lupus erythematosus. Arch Dematol 65:507-509. Abstract
11. Duperrat B (1954) Anetodermie type Schweninger-Buzzi. Bull Soc Fr dermatol Syphil 61:11
12. Temime P, Baran LR, Friedman E (1971) Anetodemie pseudotumorale et lupus erythemateux chronique. Ann Dermatol Syphil 98:141-146
13. Ryll-Nardzewski C, Kudejko T, Kudejko J (1960) Remarques sur le lupus erythemateus profond de Kaposi-Ingang et sur L'anetodermie eryhtematoide. Ann Dermatol Syphil 87:627-636
14. Venencie PY, Winkelmann RK, Moore BA (1984) Anetoderma: clinical findings, associations, and long-term follow-up evaluations. Arch Dermatol 120:1032-1039
15. Milbradt W (1937) Auftreten von anetodermia erythematosa, vitiligo und alopecia areata auf dem boden einer pluriglandularen infuffizienz. Dermatol Monatsschr 104:180-185
16. Weber FP (1917) Macular atrophy of the skin showing the early raised erythematous stage and associated with ordinary vitiligo. Proc R Soc Med 10:173-174
17. Merenlender J (1933) Sur l'etiologie de l'atrophie idiopathique de la peau: un cas d'atrophie maculeuse chez une malage atteinte de sclerose en plaques. Ann dermatol Syphil 4:593-612
18. Edelson Y, Gruppper MC (1970) Anetodermie maculeuse et lupus erythemateux. Bull Soc Fr Dermatol Syphil 77:753-756
19. Kossard S, Kronmann KR, Dicken CH, Scroeter AL (1979) Inflammatory macular atrophy: immunofluorescent and ultrastructural findings. J Am Acad Dermatol 1:325-334
20. Walshe MM (1980) Anetoderma. Br J Dermatol 103(suppl):56-57
21. Fabbri P, Lotti T, Fanconesi E (1985) A case of Pellizzari-Jadassohn anetoderma: clinical and immunopathological study. G Ital dermatol Venereol. 120:333-337
22. Bosco M, Di Leonardo S, Grana A, La Rocca E (1986) A case of Schweninger-Buzzi anetoderma: histologic and immunologic study. G Ital Dermatol Venereol 121:87-92
23. Bergman R, Friedman-Birnbaum R, Hazaz B, Cohen E, Munichor M, Lichtig C (1990) An immunofluorescence study of primary anetoderma. Clin Exp Dermatol 15:124-130
24. Hodak E, Shamai-Lubovitz O, David M, Hazaz B, Lahav M, Sandbank M (1992) Immunologic abnormalities associated with primary anetoderma. Arch Dermatol 128:799-803
25. Venencie PY, Winkelmann RK (1985) Monoclonal antibody studies in the lesions of patients with anetoderma. Arch Dermatol 121:747-749
26. Hodak E, Shamai-Lubovitz O, David M, Hazaz B, Lahav M, Sandbank M (1990) Primary anetoderma associated with a wide spectrum of autoimmune abnormalities. J Am Acad Dermatol 25:415-418
27. Stephansson EA, Niemi KM, Jouhikainen Y, Vaarala O, Palosuo T (1991) Lupus anticoagulant and the skin. A long term follow-up study of SLE patients with special reference to histopathological findings. Acta Derm Venereol 71:416-422
28. Disdier P, Harle JR, Andrac L, Verrot D, Bolla G, San Marco M, Weiller PJ (1994) Primary anetoderma associated with the antiphospholipid syndrome. J Am Acad Dermatol 30:133-134
29. Stephansson EA, Niemi KM (1995) Antiphospholipid antibodies and anetoderma: are they associated? Dermatology 191:204-209
30. Lindstrom J, Smith KJ, Skelton HG, Redfield R, Alving BM, Wagner KF, Lupton GP (1995) Increased anticardiolipin antibodies associated with the development of anetoderma in HIV-1 disease. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). Int J Dermatol 34:408-415
31. Disdier P, Christides C, Andrac-Meyer L, Rojat-Habib MC, Aillaud MF, Swiader L, Weiller-Merli C, Berbis P, Harle JR, Weiller PJ (1996) Anetoderma during antiphospholipid syndrome. 3 cases. Ann Dermatol Venereol 123:800-803. (French)
32. Montilla C, Alarcon-Segovia D (2000) Anetoderma in systemic lupus erythematosus: relationship to antiphospholipid antibodies. Lupus 9:545-547
33. Romani J, Perez F, Llobet M, Planaguma M, Pujol RM (2001) Anetoderma associated with antiphospholipid antibodies: case report and review of the literature. J Eur Acad Dermatol Venereol 15:175-178
34. Alvarez-Cuesta CC, Raya-Aguado C, Fernandez-Rippe ML, Sanchez TS, Perez-Oliva N (2001) Anetoderma in a systemic lupus erythematosus patient with anti-PCNA and antiphospholipid antibodies. Dermatology 203:348-350
35. Fernandez-Galar M, Espana A, Lloret P (2003) Systemic lupus erythematosus-associated anetoderma and antiphospholipid antibodies. Clin Exp Dermatol 28:39-42
36. Hodak E, Feuerman H, Molad Y, Monselise Y, David M (2003) Primary anetoderma: a cutaneous sign of antiphospholipid antibodies. Lupus 12:564-568
37. Bilen N, Bayramgurler D, Sikar A, Ercin C, Yilmaz A (2003) Anetoderma associated with antiphospholipid syndrome and systemic lupus erythematosus. Lupus 12:714-716
38. Sparsa A, Piette JC, Wechsler B, Amoura Z, Frances C (2003) Anetoderma and its prothrombotic abnormalities. J Am Acad Dermatol 49:1008-1012
39. Sabio JM, Tercedor J, Massare E, Jimenez-Alonso J (2004) Anetoderma associated with systemic lupus erythematosus and antiphospholipid antibodies. Lupus 13:826-827
40. Venhoff N, Miehle N, Juttner E, Peter HH, Walker UA (2005) Clinical images: anetoderma in systemic lupus erythematosus with antiphospholipid antibodies. Arthritis Rheum 52:2228
41. Rados J, Dobric I, Ledic Drvar D, Loncaric D (2005) Primary anetoderma associated with antiphospholipid antibodies and micromorphologic vascular lesions: case report and review of the literature. Acta Dermatovenereol Croat 13:177-183
42. Samarkos M, Asherson RA, Loizou S (2001) The clinical significance of IgA antiphospholipid antibodies. J Rheumatol 28:694-697
43. Frances C, Niang S, Laffitte E, le Pelletier F, Costedoat N, Piette JC (2005) Dermatologic manifestations of the antiphospholipid syndrome. Arthrit & Rheum 52:1785-1793
44. Salmon JE, Girardi G, Holmers VM (2003) Activation of complement mediates antiphospholipid antibody-induced pregnancy loss. Lupus 12:535-538
45. James WD, Berger TG, Elston DM (eds) (2006) Andrews' Diseases of the Skin. 10th edition. pp, 292, 516
46. Asherson RA, Cervera R (2003) Antiphospholipid antibodies and infections. Ann Rheum Dis 62:388-393
47. Marzano AV, Vanotti M, Alessi E (2004) Anetodermic lupus panniculitis and antiphospholipid antibodies: report of three cases. Acta Derm Venereol 84:385-388
48. Segurado MA, Guerra-Tapia A, Zarco C, Isarria MJ, Rodriguez JL (2005) Anetoderma secondary to cutaneous B-cell lymphoma. Clin Exper Dermatol 31:129-156
49. Pusterla S, Previtali S, Marziali S, Cortelazzo S, Rossi A, Barbui T, Galli M (2004) Antiphospholipid antibodies in lymphoma: prevalence and clinical significance. Hematol J 5:341-346